Log In
BCIQ
Print this Print this
 

AQS-1303

  Manage Alerts
Collapse Summary General Information
Company Aequus Pharmaceuticals Inc.
DescriptionOnce-weekly transdermal doxylamine/pyridoxine combination
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPreclinical
Standard IndicationEmesis
Indication DetailsTreat nausea
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today